Caricamento...
The potential effects of clinical antidiabetic agents on SARS‐CoV‐2
BACKGROUND: Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is currently posing significant threats to public health worldwide. It is notable that a substantial proportion of patients with sever COVID‐19 have coexisting diabetic conditions...
Salvato in:
| Pubblicato in: | J Diabetes |
|---|---|
| Autori principali: | , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley Publishing Asia Pty Ltd
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753367/ https://ncbi.nlm.nih.gov/pubmed/33210826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1753-0407.13135 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|